Lv4
448 积分 2023-08-01 加入
A 3-Decade, Single-Center Experience of Liver Transplantation for Cholangiocarcinoma: Impact of Era, Tumor Size, Location, and Neoadjuvant Therapy
12天前
已完结
Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study
27天前
已完结
胆囊癌新辅助治疗与手术时机选择
1个月前
已完结
Beneficial value of [18F]FDG PET/CT in the follow-up of patients with stage III non-small cell lung cancer (NVALT31-PET study): study protocol of a multicentre randomised controlled trial
1个月前
已完结
Neoadjuvant therapy in gall bladder cancer improves resectability and survival: a prospective study
1个月前
已完结
Time to Rethink Upfront Surgery for Resectable Intrahepatic Cholangiocarcinoma? Implications from the Neoadjuvant Experience
3个月前
已完结
Biliary tract cancer
3个月前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
4个月前
已完结
Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial
4个月前
已完结
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study
4个月前
已完结
皖公网安备34019202002308
